Yinghong Wang

机构：Tongji University, The University of Texas MD Anderson Cancer Center, Shanghai Tenth People's Hospital · ORCID：0000-0002-5148-6130

发表论文 538 篇 · 总被引 15391 次 · h-index 46

代表论文

• Worse Survival and Gastrointestinal Toxicity Outcomes Among Patients Receiving Proton Pump Inhibitors During Checkpoint Inhibitor Therapy (2025 · Journal of the National Comprehensive Cancer Network · 被引 7)
• Patterns of immune-related adverse events and treatment responses in adolescents and young adults with melanoma during initial and rechallenge immune checkpoint inhibitor therapy (2025 · Journal for ImmunoTherapy of Cancer · 被引 4)
• Microbiota and immune-related adverse events in cancer immunotherapy (2026 · Nature reviews. Cancer · 被引 3)
• Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data (2026 · Journal for ImmunoTherapy of Cancer · 被引 2)
• Disease Outcomes in Immune-Mediated Colitis: A Study Describing Initial Endoscopic and Histologic Presentations and Treatment Options (2025 · Journal of the National Comprehensive Cancer Network · 被引 2)
• Immune effector cell-associated enterocolitis (IEC-EC) across CAR-T products in myeloma and lymphoma: A real world pharmacovigilance analysis (2025 · Blood · 被引 1)